絞り込み

16555

広告

[Osteonecrosis of the jaws (ONJ) associated to antiresorptive treatment].

著者 Larsson Wexell C , Kjellman A , Akre O
Lakartidningen.2018 May 25 ; 115():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (26view , 0users)

Full Text Sources

Osteonecrosis of the jaws (ONJ) has been associated to antiresorptive treatment and is an increasing problem all over the world. ONJ is a severe adverse effect of antiresorptive treatment with bisphosphonate and denosumab used for treatment of osteoporosis, metastases from certain malignant conditions and as an adjuvant treatment in postmenopausal women with breast cancer, and of treatment with certain chemotherapeutic drugs. In this paper the epidemiology, symptoms, diagnostic features, clinical findings, and treatment are reviewed. Guidelines are presented for dental treatment, surgery and referral of patients on antiresorptive treatment.
PMID: 29809272 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード